Global Biologics Drug Development Market Research Report 2023

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.

The global Biologics Drug Development market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Biologics Drug Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Biologics Drug Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Biologics Drug Development in In-House is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Biologics Drug Development include Abbvie, Allergan, Boehringer Ingelheim, Charles River Laboratories, Catalent, Lonza Group, Amgen and Sanofi, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biologics Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Drug Development.

The Biologics Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologics Drug Development market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologics Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Clinical Manufacturing

1.2.3 Formulation Development

1.2.4 Bioassay Development

1.2.5 Analytical Services

1.3 Market by Application

1.3.1 Global Biologics Drug Development Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 In-House

1.3.3 Outsource

1.3.4 Pharma Excess

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Biologics Drug Development Market Perspective (2018-2029)

2.2 Biologics Drug Development Growth Trends by Region

2.2.1 Global Biologics Drug Development Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biologics Drug Development Historic Market Size by Region (2018-2023)

2.2.3 Biologics Drug Development Forecasted Market Size by Region (2024-2029)

2.3 Biologics Drug Development Market Dynamics

2.3.1 Biologics Drug Development Industry Trends

2.3.2 Biologics Drug Development Market Drivers

2.3.3 Biologics Drug Development Market Challenges

2.3.4 Biologics Drug Development Market Restraints

3.1 Global Top Biologics Drug Development Players by Revenue

3.1.1 Global Top Biologics Drug Development Players by Revenue (2018-2023)

3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2018-2023)

3.2 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biologics Drug Development Revenue

3.4 Global Biologics Drug Development Market Concentration Ratio

3.4.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2022

3.5 Biologics Drug Development Key Players Head office and Area Served

3.6 Key Players Biologics Drug Development Product Solution and Service

3.7 Date of Enter into Biologics Drug Development Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Biologics Drug Development Historic Market Size by Type (2018-2023)

4.2 Global Biologics Drug Development Forecasted Market Size by Type (2024-2029)

5.1 Global Biologics Drug Development Historic Market Size by Application (2018-2023)

5.2 Global Biologics Drug Development Forecasted Market Size by Application (2024-2029)

6.1 North America Biologics Drug Development Market Size (2018-2029)

6.2 North America Biologics Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biologics Drug Development Market Size by Country (2018-2023)

6.4 North America Biologics Drug Development Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Biologics Drug Development Market Size (2018-2029)

7.2 Europe Biologics Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biologics Drug Development Market Size by Country (2018-2023)

7.4 Europe Biologics Drug Development Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Biologics Drug Development Market Size (2018-2029)

8.2 Asia-Pacific Biologics Drug Development Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biologics Drug Development Market Size by Region (2018-2023)

8.4 Asia-Pacific Biologics Drug Development Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Biologics Drug Development Market Size (2018-2029)

9.2 Latin America Biologics Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biologics Drug Development Market Size by Country (2018-2023)

9.4 Latin America Biologics Drug Development Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Biologics Drug Development Market Size (2018-2029)

10.2 Middle East & Africa Biologics Drug Development Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biologics Drug Development Market Size by Country (2018-2023)

10.4 Middle East & Africa Biologics Drug Development Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbvie

11.1.1 Abbvie Company Detail

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Biologics Drug Development Introduction

11.1.4 Abbvie Revenue in Biologics Drug Development Business (2018-2023)

11.1.5 Abbvie Recent Development

11.2 Allergan

11.2.1 Allergan Company Detail

11.2.2 Allergan Business Overview

11.2.3 Allergan Biologics Drug Development Introduction

11.2.4 Allergan Revenue in Biologics Drug Development Business (2018-2023)

11.2.5 Allergan Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Detail

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Biologics Drug Development Introduction

11.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2018-2023)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Charles River Laboratories

11.4.1 Charles River Laboratories Company Detail

11.4.2 Charles River Laboratories Business Overview

11.4.3 Charles River Laboratories Biologics Drug Development Introduction

11.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2018-2023)

11.4.5 Charles River Laboratories Recent Development

11.5 Catalent

11.5.1 Catalent Company Detail

11.5.2 Catalent Business Overview

11.5.3 Catalent Biologics Drug Development Introduction

11.5.4 Catalent Revenue in Biologics Drug Development Business (2018-2023)

11.5.5 Catalent Recent Development

11.6 Lonza Group

11.6.1 Lonza Group Company Detail

11.6.2 Lonza Group Business Overview

11.6.3 Lonza Group Biologics Drug Development Introduction

11.6.4 Lonza Group Revenue in Biologics Drug Development Business (2018-2023)

11.6.5 Lonza Group Recent Development

11.7 Amgen

11.7.1 Amgen Company Detail

11.7.2 Amgen Business Overview

11.7.3 Amgen Biologics Drug Development Introduction

11.7.4 Amgen Revenue in Biologics Drug Development Business (2018-2023)

11.7.5 Amgen Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Biologics Drug Development Introduction

11.8.4 Sanofi Revenue in Biologics Drug Development Business (2018-2023)

11.8.5 Sanofi Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Biologics Drug Development Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Clinical Manufacturing

    Table 3. Key Players of Formulation Development

    Table 4. Key Players of Bioassay Development

    Table 5. Key Players of Analytical Services

    Table 6. Global Biologics Drug Development Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Biologics Drug Development Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Biologics Drug Development Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Biologics Drug Development Market Share by Region (2018-2023)

    Table 10. Global Biologics Drug Development Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Biologics Drug Development Market Share by Region (2024-2029)

    Table 12. Biologics Drug Development Market Trends

    Table 13. Biologics Drug Development Market Drivers

    Table 14. Biologics Drug Development Market Challenges

    Table 15. Biologics Drug Development Market Restraints

    Table 16. Global Biologics Drug Development Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Biologics Drug Development Market Share by Players (2018-2023)

    Table 18. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2022)

    Table 19. Ranking of Global Top Biologics Drug Development Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Biologics Drug Development Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Biologics Drug Development Product Solution and Service

    Table 23. Date of Enter into Biologics Drug Development Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Biologics Drug Development Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Biologics Drug Development Revenue Market Share by Type (2018-2023)

    Table 27. Global Biologics Drug Development Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Biologics Drug Development Revenue Market Share by Type (2024-2029)

    Table 29. Global Biologics Drug Development Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Biologics Drug Development Revenue Market Share by Application (2018-2023)

    Table 31. Global Biologics Drug Development Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Biologics Drug Development Revenue Market Share by Application (2024-2029)

    Table 33. North America Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Biologics Drug Development Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Biologics Drug Development Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Biologics Drug Development Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Biologics Drug Development Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Biologics Drug Development Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Biologics Drug Development Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Biologics Drug Development Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Biologics Drug Development Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Biologics Drug Development Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Biologics Drug Development Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Biologics Drug Development Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Abbvie Company Detail

    Table 49. Abbvie Business Overview

    Table 50. Abbvie Biologics Drug Development Product

    Table 51. Abbvie Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 52. Abbvie Recent Development

    Table 53. Allergan Company Detail

    Table 54. Allergan Business Overview

    Table 55. Allergan Biologics Drug Development Product

    Table 56. Allergan Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 57. Allergan Recent Development

    Table 58. Boehringer Ingelheim Company Detail

    Table 59. Boehringer Ingelheim Business Overview

    Table 60. Boehringer Ingelheim Biologics Drug Development Product

    Table 61. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 62. Boehringer Ingelheim Recent Development

    Table 63. Charles River Laboratories Company Detail

    Table 64. Charles River Laboratories Business Overview

    Table 65. Charles River Laboratories Biologics Drug Development Product

    Table 66. Charles River Laboratories Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 67. Charles River Laboratories Recent Development

    Table 68. Catalent Company Detail

    Table 69. Catalent Business Overview

    Table 70. Catalent Biologics Drug Development Product

    Table 71. Catalent Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 72. Catalent Recent Development

    Table 73. Lonza Group Company Detail

    Table 74. Lonza Group Business Overview

    Table 75. Lonza Group Biologics Drug Development Product

    Table 76. Lonza Group Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 77. Lonza Group Recent Development

    Table 78. Amgen Company Detail

    Table 79. Amgen Business Overview

    Table 80. Amgen Biologics Drug Development Product

    Table 81. Amgen Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 82. Amgen Recent Development

    Table 83. Sanofi Company Detail

    Table 84. Sanofi Business Overview

    Table 85. Sanofi Biologics Drug Development Product

    Table 86. Sanofi Revenue in Biologics Drug Development Business (2018-2023) & (US$ Million)

    Table 87. Sanofi Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Biologics Drug Development Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Biologics Drug Development Market Share by Type: 2022 VS 2029

    Figure 3. Clinical Manufacturing Features

    Figure 4. Formulation Development Features

    Figure 5. Bioassay Development Features

    Figure 6. Analytical Services Features

    Figure 7. Global Biologics Drug Development Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Biologics Drug Development Market Share by Application: 2022 VS 2029

    Figure 9. In-House Case Studies

    Figure 10. Outsource Case Studies

    Figure 11. Pharma Excess Case Studies

    Figure 12. Biologics Drug Development Report Years Considered

    Figure 13. Global Biologics Drug Development Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Biologics Drug Development Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Biologics Drug Development Market Share by Region: 2022 VS 2029

    Figure 16. Global Biologics Drug Development Market Share by Players in 2022

    Figure 17. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Biologics Drug Development Revenue in 2022

    Figure 19. North America Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Biologics Drug Development Market Share by Country (2018-2029)

    Figure 21. United States Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Biologics Drug Development Market Share by Country (2018-2029)

    Figure 25. Germany Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Biologics Drug Development Market Share by Region (2018-2029)

    Figure 33. China Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Biologics Drug Development Market Share by Country (2018-2029)

    Figure 41. Mexico Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Biologics Drug Development Market Share by Country (2018-2029)

    Figure 45. Turkey Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Biologics Drug Development Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 48. Allergan Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 49. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 50. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 51. Catalent Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 52. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 53. Amgen Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 54. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed